Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Yiviva Logo
Yiviva Growth Score
19
CB Rank
216579
Heat Score
33
Yiviva develops medicines that improve longevity by preventing, treating, and curing complex, aging-associated diseases.
Founded
obfuscation
PrivateSeries A New York, New York, United States1-10 yiviva.com/
Biotechnology
Health Care
Overview

Yiviva
Total Funding
obfuscation
Growth Score
19
Heat Score
33

Total Funding
obfuscation
Series A raised
obfuscation
Growth Score19
-3 pts
in past quarter
Heat Score 33
-7 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Yiviva

CB Rank
216579
Yiviva develops medicines that improve longevity by preventing, treating, and curing complex, aging-associated diseases.
Founded
obfuscation
PrivateSeries A New York, New York, United States1-10 yiviva.com/
Biotechnology
Health Care

Funding Rounds

Series A
OBF
in
obfuscation
Venture - Series Unknown
OBF
in
obfuscation

Key People

Details

Legal Name Yiviva Inc.
Operating Status Active
Company Type For Profit
Founders  Liu Shwu-Huey, Peikwen Cheng
About the Company
Yiviva develops medicines that improve longevity by preventing, treating, and curing complex, aging-associated diseases. It treats cancer, chronic diseases, and inflammatory diseases. Yiviva improves patient outcomes through a sophisticated multi-targeted approach that treats the entire person as a system.
Predictions & Insights

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Growth Insight

Products & Services

YIV-906
A botanical drug acting as an immunomodulator in the tumor microenvironment and a cytoprotector in the gastrointestinal tract to support cancer treatment and inflammatory bowel disease.
YIV-111
A multi-target drug candidate aimed at preventing and treating respiratory diseases by reducing inflammation, fibrosis, oxidative stress, and microbial virulence.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series A - Yiviva Logo
Series A - Yiviva
—
obfuscation
— Series A
obfuscation
Series A - Yiviva Logo
Series A - Yiviva
—
obfuscation
— Series A
obfuscation
Series A - Yiviva Logo
Series A - Yiviva
—
obfuscation
— Series A
obfuscation
Series A - Yiviva Logo
Series A - Yiviva
—
obfuscation
— Series A
obfuscation
Series A - Yiviva Logo
Series A - Yiviva
—
obfuscation
— Series A

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series A - Yiviva Logo
Series A - Yiviva
—
obfuscation
— Series A
obfuscation
Series A - Yiviva Logo
Series A - Yiviva
—
obfuscation
— Series A
obfuscation
Series A - Yiviva Logo
Series A - Yiviva
—
obfuscation
— Series A
obfuscation
Series A - Yiviva Logo
Series A - Yiviva
—
obfuscation
— Series A
obfuscation
Series A - Yiviva Logo
Series A - Yiviva
—
obfuscation
— Series A

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 2 Contacts 4

Employee Profiles

News

News and Press

News•Jul 8, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jul 7, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jul 7, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Feb 11, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

434

IT Spend

$69.6KThis year, Yiviva is projected to spend $69.6K on IT, according to Aberdeen.

Actively Used Products

14Yiviva uses 14 technology products and services including HTML5, Lightbox, and  Modernizr, according to G2 Stack.

Active Website Tech Count

10Yiviva is actively using 10 technologies for its website, according to BuiltWith. These include CommonCrawl Top 50m, DNSSEC, and  Google Maps.

Total IP

4Yiviva has registered 4 trademarks with the most popular class being 'Pharmaceutical, veterinary and sanitary products', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Yiviva's headquarters? Yiviva is located in New York, New York, United States.When was the last funding round for Yiviva? Yiviva closed its last funding round on
obfuscation
from a Series A round.Who are Yiviva's competitors? Alternatives and possible competitors to Yiviva may include Insilico Medicine, Ginkgo Bioworks, and  Antheia.How much funding has Yiviva raised to date? Yiviva has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(411cf44 1)
|